StockMacro
Menu

Universal Health Realty Income Trust

$37.22 -12% in 6 monthsMarket cap $517.3M

UHT on XNYS, Real Estate, job postings

Measures activity, not value. Not investment advice.

News volume 15 times its usual week, though quarterly revenue was flat at $25.3M.

  • GoodNet income up 12% to $20.2M over the last 12 months

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

Industry
Real estate investment trusts (Real Estate)
Employees
5
Website
uhrit.com
Listed
NYSE, US
Last results
27 Oct 2026
Next results
expected around 24 Feb 2027 (an estimate: a year ago it reported on 25 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $25.3M, net income $4.9M.
Quarter to 31 Dec 2021: revenue $21.4M, net income $91.6MQuarter to 31 Dec 2021: revenue $21.4M, net income $91.6MQuarter to 31 Mar 2022: revenue $22.2M, net income $5.4MQuarter to 31 Mar 2022: revenue $22.2M, net income $5.4MQuarter to 30 Jun 2022: revenue $22.2M, net income $5.2MQuarter to 30 Jun 2022: revenue $22.2M, net income $5.2MQuarter to 30 Sep 2022: revenue $22.2M, net income $4.8MQuarter to 30 Sep 2022: revenue $22.2M, net income $4.8MQuarter to 31 Dec 2022: revenue $24.1M, net income $5.6MQuarter to 31 Dec 2022: revenue $24.1M, net income $5.6MQuarter to 31 Mar 2023: revenue $23.2M, net income $4.5MQuarter to 31 Mar 2023: revenue $23.2M, net income $4.5MQuarter to 30 Jun 2023: revenue $23.8M, net income $3.5MQuarter to 30 Jun 2023: revenue $23.8M, net income $3.5MQuarter to 30 Sep 2023: revenue $24.2M, net income $3.9MQuarter to 30 Sep 2023: revenue $24.2M, net income $3.9MQuarter to 31 Dec 2023: revenue $24.3M, net income $3.6MQuarter to 31 Dec 2023: revenue $24.3M, net income $3.6MQuarter to 31 Mar 2024: revenue $25.1M, net income $5.3MQuarter to 31 Mar 2024: revenue $25.1M, net income $5.3MQuarter to 30 Jun 2024: revenue $24.7M, net income $5.3MQuarter to 30 Jun 2024: revenue $24.7M, net income $5.3MQuarter to 30 Sep 2024: revenue $24.5M, net income $4.0MQuarter to 30 Sep 2024: revenue $24.5M, net income $4.0MQuarter to 31 Dec 2024: revenue $24.6M, net income $4.7MQuarter to 31 Dec 2024: revenue $24.6M, net income $4.7MQuarter to 31 Mar 2025: revenue $24.5M, net income $4.8MQuarter to 31 Mar 2025: revenue $24.5M, net income $4.8MQuarter to 30 Jun 2025: revenue $24.9M, net income $4.5MQuarter to 30 Jun 2025: revenue $24.9M, net income $4.5MQuarter to 30 Sep 2025: revenue $25.3M, net income $4.0MQuarter to 30 Sep 2025: revenue $25.3M, net income $4.0MQuarter to 31 Dec 2025: revenue $24.5M, net income $4.3MQuarter to 31 Dec 2025: revenue $24.5M, net income $4.3MQuarter to 31 Mar 2026: revenue $24.5M, net income $5.0MQuarter to 31 Mar 2026: revenue $24.5M, net income $5.0MQuarter to 30 Jun 2026: revenue $25.0M, net income $5.9MQuarter to 30 Jun 2026: revenue $25.0M, net income $5.9MQuarter to 30 Sep 2026: revenue $25.3M, net income $4.9MQuarter to 30 Sep 2026: revenue $25.3M, net income $4.9M
31 Dec 2021RevenueNet incometallest bar $91.6M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$25.3M$4.9M
30 Jun 2026$25.0M$5.9M
31 Mar 2026$24.5M$5.0M
31 Dec 2025$24.5M$4.3M
30 Sep 2025$25.3M$4.0M
30 Jun 2025$24.9M$4.5M
31 Mar 2025$24.5M$4.8M
31 Dec 2024$24.6M$4.7M
30 Sep 2024$24.5M$4.0M
30 Jun 2024$24.7M$5.3M
31 Mar 2024$25.1M$5.3M
31 Dec 2023$24.3M$3.6M
30 Sep 2023$24.2M$3.9M
30 Jun 2023$23.8M$3.5M
31 Mar 2023$23.2M$4.5M
31 Dec 2022$24.1M$5.6M
30 Sep 2022$22.2M$4.8M
30 Jun 2022$22.2M$5.2M
31 Mar 2022$22.2M$5.4M
31 Dec 2021$21.4M$91.6M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $99.3M $99.4M
Revenue growthRevenue of the last 12 months compared with the 12 months before. 0% +5.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $20.2M $17.9M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $1.45 $1.29
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 68.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 35.9% 35.8% 37.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 20.3% 18.1% 14.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 13.5% 4.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $6.5M $6.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $377.7M $357.1M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $371.2M $350.1M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 2.7 1.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $10.04
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 25.6 24.5
P/SPrice to sales: market cap divided by revenue of the last 12 months. 5.2 4.5
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 8.9 9.8
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.7 1.1
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 8.0% 5.1%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Universal Health Realty Income TrustUHT (this company) $517.3M25.65.20%20.3%
Chimera InvestmentCIM $532.4Mloss–––
Brandywine Realty TrustBDN $488.0Mloss–––
TPG RE Finance TrustTRTX $482.3M10.6–––
FrontView REITFVR $480.2Mloss6.7+8.4%-0.0%
MFA FinancialMFA $584.1Mloss–––

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-4.4%

175 13F filers vs 183

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

62%

8.6M shares held by 13F filers (30 Sep 2026) of 13.9M outstanding (31 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.0%

280K shares sold short (30 Oct 2026) of 13.9M outstanding (31 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.1

280K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-13%

320K shares sold short in the report before, 280K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

36%

36% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+0.2%

$25.3M vs $25.3M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

15

15 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

15×

15 articles in the last 7 days; its usual week has 1.

Price $37.22 on 20 Nov 2026, -6.2% over 12 months (12-month range $36.43 to $45.82)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $453K).
Revenue per quarter. Revenue $25.3M in the latest quarter, +0.2% on a year earlier.
Capital spending per quarter. Capital spending $22K in the latest quarter.
Institutional holders (13F filers). 175 13F filers reported holding it in the latest 13F quarter, +4.8% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
11 Jun 20268-K and other filingsDirector or officer change
11 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Jun 20258-K and other filingsDirector or officer change
12 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Jun 20248-K and other filingsDirector or officer change
6 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 May 2024Sharp changeMany funds opening a new position: many funds opening a new position, 27 vs usual 12.50 (2024-03-31); 2.2x the same period a year earlier
8 Jun 20238-K and other filingsDirector or officer change
8 Jun 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Dec 20228-K and other filingsDirector or officer change
1 Dec 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Jan 20228-K and other filingsCompleted an acquisition or asset sale
Insider net buying (open market)
Month from 1 May 2022: $120K published
Month from 1 Sep 2022: $194K published
Month from 1 Mar 2023: $146K published
Month from 1 May 2023: $103K published
Month from 1 Apr 2024: $208K published
Month from 1 May 2024: $75K published
Month from 1 Oct 2025: $453K published
Revenue per quarter
Quarter ended 31 Dec 2021: $21.4M, +8.0% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $22.2M, +7.1% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $22.2M, +6.2% on a year earlier; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $22.2M, +4.5% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $24.1M, +13% on a year earlier; public on 28 Feb 2023
Quarter ended 31 Mar 2023: $23.2M, +4.7% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $23.8M, +7.4% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $24.2M, +9.4% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $24.3M, +0.8% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $25.1M, +8.2% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $24.7M, +3.9% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $24.5M, +1.1% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $24.6M, +1.3% on a year earlier; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $24.5M, -2.4% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $24.9M, +0.5% on a year earlier; public on 9 Aug 2025
Quarter ended 30 Sep 2025: $25.3M, +3.3% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $24.5M, -0.7% on a year earlier; public on 26 Feb 2026
Quarter ended 31 Mar 2026: $24.5M, -0.1% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $25.0M, +0.5% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $25.3M, +0.2% on a year earlier; public on 7 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $0; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $13.6M; public on 7 May 2022
Quarter ended 30 Jun 2022: $15K; public on 9 Aug 2022
Quarter ended 31 Dec 2023: $22K; public on 28 Feb 2024
Institutional holders (13F filers)
31 Dec 2021 report: 147; public on 14 Feb 2022
31 Mar 2022 report: 150; public on 16 May 2022
30 Jun 2022 report: 145; public on 15 Aug 2022
30 Sep 2022 report: 132; public on 14 Nov 2022
31 Dec 2022 report: 148; public on 14 Feb 2023
31 Mar 2023 report: 154; public on 15 May 2023
30 Jun 2023 report: 135; public on 14 Aug 2023
30 Sep 2023 report: 140; public on 14 Nov 2023
31 Dec 2023 report: 136; public on 14 Feb 2024
31 Mar 2024 report: 146; public on 15 May 2024
30 Jun 2024 report: 149; public on 14 Aug 2024
30 Sep 2024 report: 162; public on 14 Nov 2024
31 Dec 2024 report: 158; public on 14 Feb 2025
31 Mar 2025 report: 164; public on 15 May 2025
30 Jun 2025 report: 163; public on 14 Aug 2025
30 Sep 2025 report: 167; public on 14 Nov 2025
31 Dec 2025 report: 173; public on 17 Feb 2026
31 Mar 2026 report: 181; public on 15 May 2026
30 Jun 2026 report: 183; public on 14 Aug 2026
30 Sep 2026 report: 175; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $453K (30 Oct 2025), 4.4× its normal reading; higher than 100% of its own history.
  • Insider net buying (open market): Insiders bought a net $0 in the last 12 months (the 12 months before: $453K).
  • Revenue per quarter: Revenue $25.3M in the latest quarter, +0.2% on a year earlier.
  • Capital spending per quarter: Capital spending $22K in the latest quarter.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 15 insider trades

No trades in the last 90 days; the latest was filed 30 Oct 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
30 Oct 2025Alan B MillerPresident, and CEOBuy12,247$37.02$453KForm 4
9 May 2024Robert F McCaddenDirectorBuy2,000$37.38$75KForm 4
26 Apr 2024Alan B MillerPresident, and CEOBuy6,000$34.65$208KForm 4
3 May 2023Alan B MillerPresident, and CEOBuy2,395$43.18$103KForm 4
10 Mar 2023Robert F McCaddenDirectorBuy1,000$48.12$48KForm 4
8 Mar 2023Alan B MillerPresident, and CEOBuy2,000$48.81$98KForm 4
15 Sep 2022Alan B MillerPresident, and CEOBuy2,000$48.32$97KForm 4
9 Sep 2022Alan B MillerPresident, and CEOBuy2,000$48.90$98KForm 4

175 institutions reported shares at the end of Q3 2026, 62% of the shares outstanding; 18 opened a position, 24 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.1.4M10.3%$53.7M-57K-3.8%
Vanguard Portfolio Management LLC887K6.38%$33.2M+41K+4.9%
Vanguard Capital Management LLC565K4.06%$21.1M+3,714+0.7%
Two Sigma Investments, LP376K2.71%$14.1M+147K+64%
State Street Corp369K2.66%$13.8M-8,387-2.2%
Geode Capital Management, LLC369K2.65%$13.8M-6,826-1.8%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.364K2.62%$13.6M+10K+2.9%
Qube Research & Technologies Ltd302K2.17%$11.3M+95K+46%
Charles Schwab Investment Management Inc299K2.15%$11.2M+146K+96%
Citadel Advisors LLC249K1.79%$9.3M+48K+24%

Company events

All 22 company events

In 12 months: 1 major agreement, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
11 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
24 Apr 2026Signed a major agreementSame filing: took on new debt8-K
12 Jun 2025Director or officer changeSame filing: shareholder vote results8-K
2 Oct 2024Signed a major agreementSame filing: took on new debt8-K
6 Jun 2024Director or officer changeSame filing: shareholder vote results8-K
8 Jun 2023Director or officer changeSame filing: shareholder vote results8-K
16 May 2023Signed a major agreementSame filing: took on new debt8-K
1 Dec 2022Director or officer change8-K

The 5 newest of 85 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 11 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 11 Jun 2026Filings record

    Director or officer change

  3. 31 Oct 2025Insiders record

    MILLER ALAN B (President, and CEO) bought 12,247 shares of UHT ($453,384) (dated 30 Oct 2025)

  4. 12 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 12 Jun 2025Filings record

    Director or officer change

  6. 6 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 6 Jun 2024Filings record

    Director or officer change

  8. 15 May 2024Institutional holdings change

    saw 27 13F filers open a new position in the quarter ended 31 Mar 2024, 2.2× the same quarter last year.

    Same quarter last year: 12; its normal quarter is 12.5.

    See the evidence
    This period
    27 (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    12.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +4.8
    Same quarter last year
    12
    History used
    3,835 days
    2022-03-31: 132022-06-30: 152022-09-30: 142022-12-31: 282023-03-31: 122023-06-30: 72023-09-30: 112023-12-31: 92024-03-31: 27
    the quarter ended 31 Mar 20248 earlier quartersnormal: 12.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  9. 10 May 2024Insiders record

    McCadden Robert F (director) bought 2,000 shares of UHT ($74,760) (dated 9 May 2024)

  10. 27 Apr 2024Insiders record

    MILLER ALAN B (President, and CEO) bought 6,000 shares of UHT ($207,900) (dated 26 Apr 2024)

  11. 8 Jun 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 8 Jun 2023Filings record

    Director or officer change

  13. 4 May 2023Insiders record

    MILLER ALAN B (President, and CEO) bought 2,395 shares of UHT ($103,416) (dated 3 May 2023)

  14. 11 Mar 2023Insiders record

    McCadden Robert F (director) bought 1,000 shares of UHT ($48,120) (dated 10 Mar 2023)

  15. 9 Mar 2023Insiders record

    MILLER ALAN B (President, and CEO) bought 2,000 shares of UHT ($97,620) (dated 8 Mar 2023)

  16. 1 Dec 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 1 Dec 2022Filings record

    Director or officer change

  18. 16 Sep 2022Insiders record

    MILLER ALAN B (President, and CEO) bought 2,000 shares of UHT ($96,640) (dated 15 Sep 2022)

  19. 10 Sep 2022Insiders record

    MILLER ALAN B (President, and CEO) bought 2,000 shares of UHT ($97,800) (dated 9 Sep 2022)

  20. 13 May 2022Insiders record

    McCadden Robert F (director) bought 2,500 shares of UHT ($119,665) (dated 12 May 2022)

  21. 4 Jan 2022Filings record

    Completed an acquisition or asset sale

  22. 11 Sep 2021Insiders record

    Domb Michael Allan (director) bought 5,800 shares of UHT ($325,950) (dated 10 Sep 2021)

  23. 19 Aug 2021Insiders record

    MILLER ALAN B (President, and CEO) bought 4,500 shares of UHT ($257,220) (dated 18 Aug 2021)

  24. 11 Sep 2020Insiders record

    Domb Michael Allan (director) bought 2,200 shares of UHT ($145,200) (dated 10 Sep 2020)

  25. 1 Aug 2020Insiders record

    MILLER ALAN B (President, and CEO) bought 1,500 shares of UHT ($102,465) (dated 31 Jul 2020)

  26. 31 Jul 2020Insiders record

    McCadden Robert F (director) bought 1,000 shares of UHT ($68,330) (dated 30 Jul 2020)

  27. 14 May 2019Financials change

    reported revenue of $2.2M for the quarter ended 31 Mar 2019, 88% below the same quarter last year.

    Same quarter last year: $18.5M; its normal quarter is $18.4M.

    See the evidence
    This period
    $2.2M (the quarter ended 31 Mar 2019)
    Normal quarter (median of 8 earlier)
    $18.4M
    Typical spread (median absolute deviation)
    $294K
    How far from its usual level
    -8.8
    Same quarter last year
    $18.5M
    History used
    3,196 days
    2017-03-31: $17.8M2017-06-30: $18.1M2017-09-30: $18.2M2017-12-31: $18.3M2018-03-31: $18.5M2018-06-30: $20.1M2018-09-30: $18.8M2018-12-31: $18.7M2019-03-31: $2.2M
    the quarter ended 31 Mar 20198 earlier quartersnormal: $18.4M

    Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  28. 17 Jul 2018Filings record

    Director or officer change

  29. 29 Mar 2018Filings record

    A major agreement ended

  30. 22 Mar 2018Filings record

    Director or officer change

  31. 8 Mar 2018Filings record

    Director or officer change

  32. 12 Sep 2017Filings record

    Director or officer change

  33. 24 Jan 2017Filings record

    Director or officer change

Not listed: 100 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000798783
Ticker
UHT
Domain
uhrit.com
Hq location
PA|KING OF PRUSSIA|19406 (1 unverified)
Name
3811 Bell Medical Properties, LLC, 5004 Pool Road Properties, LP, 653 Town Center Investments, LLC, 653 Town Center Phase II, LLC73 Medical Building, LLC and 51 more
Uei
J3MVWYJ38MP4
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)111 records29 Feb 2016 to 6 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)801 data points31 Dec 2008 to 31 Oct 2026
  • SEC Form 4 insider transactions15 records, 60 data points22 Nov 2017 to 30 Oct 2025
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards21 data points1 Oct 2009 to 1 Apr 2011